Erythroid/megakaryocytic differentiation confers BCL-XL dependency and venetoclax resistance in acute myeloid leukemia
Heikki Kuusanmäki(University of Copenhagen), Satu Mustjoki(University of Helsinki)
Cited by 123
Related Papers
Phenotype-based drug screening reveals association between venetoclax response and differentiation stage in acute myeloid leukemia
|Haematologica|2019|184
Somatic mutations in clonally expanded cytotoxic T lymphocytes in patients with newly diagnosed rheumatoid arthritis
|Nature Communications|2017|123
Single-cell characterization of anti–LAG-3 and anti–PD-1 combination treatment in patients with melanoma
|Journal of Clinical Investigation|2023|93
Novel somatic mutations in large granular lymphocytic leukemia affecting the STAT-pathway and T-cell activation
|Blood Cancer Journal|2013|63